Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using NMR for ligand discovery and optimization.

Hugo O Villar1, Jiangli Yan, Mark R Hansen

  • 1Triad Therapeutics, 9381 Judicial Dr., San Diego, California 92121, USA. hugo@altoris.com

Current Opinion in Chemical Biology
|August 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intramolecular Ring-Opening Decomposition of Aryl Azetidines.

ACS medicinal chemistry letters·2021
Same author

Molecular Diversity Assessment using Chemotypes.

Current computer-aided drug design·2021
Same author

Cyclic Peptide Design Guided by Residual Dipolar Couplings, J-Couplings, and Intramolecular Hydrogen Bond Analysis.

The Journal of organic chemistry·2019
Same author

Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.

Journal of medicinal chemistry·2017
Same author

Depletion of Gut-Resident CCR5<sup>+</sup> Cells for HIV Cure Strategies.

AIDS research and human retroviruses·2017
Same author

Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.

Journal of medicinal chemistry·2017
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
Same journal

Chemigenetic fluorescent biosensors in biological imaging - New trends and advances.

Current opinion in chemical biology·2026
See all related articles

Recent advances in Nuclear Magnetic Resonance (NMR) enhance drug discovery. NMR is now routinely used for screening novel ligands, structure-guided drug design, and metabonomics, accelerating development.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Analytical Chemistry

Background:

  • Nuclear Magnetic Resonance (NMR) technology has seen significant advancements.
  • These developments have renewed interest in NMR applications for drug discovery and development.
  • NMR offers unique versatility across various stages of the pharmaceutical pipeline.

Purpose of the Study:

  • To provide an overview of recent NMR developments in drug discovery and optimization.
  • To highlight the expanding role of NMR in identifying novel ligands and molecular structures.
  • To discuss the routine application of NMR in structure-guided drug design and metabonomics.

Main Methods:

  • Review of recent technological advances in NMR spectroscopy.
  • Analysis of NMR applications in ligand screening and fragment-based drug design.

Related Experiment Videos

  • Examination of NMR's role in structure-guided design and metabonomics.

    • Main Results:

    • NMR is increasingly utilized for screening low molecular weight compounds and novel ligands.
    • NMR-based structure-guided drug design is becoming a standard practice.
    • Metabonomic studies using NMR are now routinely integrated into research.

    Conclusions:

    • Recent NMR innovations significantly benefit drug discovery and development processes.
    • The broad applicability of NMR spans from initial screening to advanced design and analysis.
    • NMR is a pivotal technology for modern pharmaceutical research and optimization.